Microdosing: Difference between revisions
From BurnZero
mNo edit summary |
mNo edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''A microdose is a dose of [[Psychedelics|psychedelic]] medicine which is sub perceptual in nature, meaning taking the dose does not cause any change in perception / consciousness. A microdose is | '''A microdose is a dose of [[Psychedelics|psychedelic]] medicine which is sub perceptual in nature, meaning taking the dose does not cause any change in perception / consciousness. A microdose is often defined as approximately one tenth of a [[Psychedelics|psychedelic]] dose, repeated every 3-5 days.''' | ||
In the vast majority of human studies [[microdosing]] has been shown to have no effect and even in some have shown negative effects such as neuroticism or even the potential to cause valvular heart disease. However, an animal study has found that 0.25g [[psilocybin]] (equivalent human dose) increases resilience to stress, lowers compulsive actions, and strengthens cortical connections to the paraventricular thalamic nucleus<ref>'''Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats''' Kat F. Kiilerich, Joe Lorenz. https://www.nature.com/articles/s41380-023-02280-z</ref>. Some recent studies have shown that LSD microdosing was found to increase neural complexity<ref>Murray, C.H., Frohlich, J., Haggarty, C.J. ''et al.'' | In the vast majority of human studies [[microdosing]] has been shown to have no effect and even in some have shown negative effects<ref>'''Motives and Side-Effects of Microdosing With Psychedelics Among Users.''' Hutten, N., Mason, N., Dolder, P., & Kuypers, K. (2019). ''International Journal of Neuropsychopharmacology'', 22, 426 - 434. https://academic.oup.com/ijnp/article/22/7/426/5509881</ref> such as increased neuroticism<ref>'''A systematic study of microdosing psychedelics'''. ''PLoS ONE'', 14. Polito, V., & Stevenson, R. (2018). https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211023.</ref> or even inducing the potential to cause valvular heart disease. However, an animal study has found that 0.25g [[psilocybin]] (equivalent human dose) increases resilience to stress, lowers compulsive actions, and strengthens cortical connections to the paraventricular thalamic nucleus<ref>'''Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats''' Kat F. Kiilerich, Joe Lorenz. https://www.nature.com/articles/s41380-023-02280-z</ref>. Some recent studies have shown that LSD microdosing was found to increase neural complexity<ref>'''Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine'''. Murray, C.H., Frohlich, J., Haggarty, C.J. ''et al.'' ''Neuropsychopharmacol.'' (2024). <nowiki>https://doi.org/10.1038/s41386-024-01809-2</nowiki></ref>, increase in sleep duration<ref>https://www.nature.com/articles/s41398-024-02900-4</ref> and have an antidepressant effect<ref>'''Molla, H., et al. (2024). "Greater subjective effects of a low dose of LSD in participants with depressed mood."''' Neuropsychopharmacology 49(5): 774-781. https://www.nature.com/articles/s41386-023-01772-4</ref>. | ||
Reference | Reference | ||
Latest revision as of 05:47, 8 May 2024
A microdose is a dose of psychedelic medicine which is sub perceptual in nature, meaning taking the dose does not cause any change in perception / consciousness. A microdose is often defined as approximately one tenth of a psychedelic dose, repeated every 3-5 days.
In the vast majority of human studies microdosing has been shown to have no effect and even in some have shown negative effects[1] such as increased neuroticism[2] or even inducing the potential to cause valvular heart disease. However, an animal study has found that 0.25g psilocybin (equivalent human dose) increases resilience to stress, lowers compulsive actions, and strengthens cortical connections to the paraventricular thalamic nucleus[3]. Some recent studies have shown that LSD microdosing was found to increase neural complexity[4], increase in sleep duration[5] and have an antidepressant effect[6].
Reference
- ↑ Motives and Side-Effects of Microdosing With Psychedelics Among Users. Hutten, N., Mason, N., Dolder, P., & Kuypers, K. (2019). International Journal of Neuropsychopharmacology, 22, 426 - 434. https://academic.oup.com/ijnp/article/22/7/426/5509881
- ↑ A systematic study of microdosing psychedelics. PLoS ONE, 14. Polito, V., & Stevenson, R. (2018). https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211023.
- ↑ Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats Kat F. Kiilerich, Joe Lorenz. https://www.nature.com/articles/s41380-023-02280-z
- ↑ Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Murray, C.H., Frohlich, J., Haggarty, C.J. et al. Neuropsychopharmacol. (2024). https://doi.org/10.1038/s41386-024-01809-2
- ↑ https://www.nature.com/articles/s41398-024-02900-4
- ↑ Molla, H., et al. (2024). "Greater subjective effects of a low dose of LSD in participants with depressed mood." Neuropsychopharmacology 49(5): 774-781. https://www.nature.com/articles/s41386-023-01772-4